Wave Life Sciences

biotechnology company

WVE Nasdaq ISIN SG9999014716 SEC CIK 1631574 LEI 54930070006GPKFYZ813
Follow Wave Life Sciences Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $13.2M +72.9% vs same quarter last year
Net income −$61.9M −15% vs same quarter last year
EPS, diluted −$0.30 +6.3% vs same quarter last year
Operating cash flow −$60.1M −34.6% vs same quarter last year
Revenue by quarter
$9.2M
$8.7M
$7.6M
$17.2M
$38.2M
$2.3M
$13.2M
Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income14 fiscal years
  • Revenue
  • Net income
−$300M−$200M−$100M$0$100M$200MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$42.7M−$204.4M
FY24$108.3M−$97M
FY23$113.3M−$57.5M
FY22$3.6M−$161.8M
FY21$41M−$122.2M
FY20$20.1M−$149.9M
FY19$16M−$193.6M
FY18$14.4M−$146.7M
FY17$3.9M−$102M
FY16$1.1M−$55.7M
FY15$152K−$19.2M
FY14-−$5.2M
FY13-−$3.3M
FY12--
MarginsShare of revenue
  • Operating margin
  • Net margin
−15000%−10000%−5000%0%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearOperating marginNet margin
FY25−504.1%−478.4%
FY24−101.9%−89.6%
FY23−60%−50.7%
FY22−4459.3%−4434.1%
FY21−310.1%−298.3%
FY20−763.9%−746.7%
FY19−1303.4%−1211.5%
FY18−1106.7%−1017.4%
FY17−2630.1%−2619.6%
FY16−5102.6%−5097.1%
FY15−12696.1%−12631.6%
FY14--
FY13--
FY12--
Free cash flowOperating cash flow minus capital expenditure
−$200M−$150M−$100M−$50M$0FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$188.2M
FY24−$152M
FY23−$20.5M
FY22−$129.1M
FY21−$89.6M
FY20−$117.3M
FY19−$192.1M
FY18−$32.8M
FY17−$102.6M
FY16−$37.5M
FY15−$14.4M
FY14−$5M
FY13−$3.6M
FY12-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Wave Life Sciences
  • Healthcare median
−15000%−10000%−5000%0%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearWave Life SciencesHealthcare median
FY25−478.4%−30.6%
FY24−89.6%−47%
FY23−50.7%−58%
FY22−4434.1%−80.4%
FY21−298.3%−71.8%
FY20−746.7%−62.2%
FY19−1211.5%−46.2%
FY18−1017.4%−49.6%
FY17−2619.6%−45.9%
FY16−5097.1%−36%
FY15−12631.6%−37.8%
FY14-−35.5%
FY13-−37.1%
FY12-−29.1%